IN THE NEWS: Updates in treatment and management of metastatic castration-resistant prostate cancer

OncLive

Elisabeth Heath, M.D., FACP, medical oncologist, leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT at Karmanos, is featured on OncLive Insights and interviewed by Tanya Dorff, M.D. of City of Hope. Dr. Heath discusses a number of topics during this multi-series interview surrounding the current treatment and clinical trials for metastatic castration-resistant prostate cancer.

• Episode 1: Overview on Metastic CRPC and Available Treatment Options
• Episode 2: Practical Considerations for Sequencing Cabazitaxel in Metastatic CRPC
• Episode 3: The PROSELICA Trial: Cabazitaxel Dosing in Metastatic CRPC
• Episode 4: Interpreting Data From the CARD Trial in Metastatic CRPC
  
• Episode 5: Metastatic CRPC: Considering Use of Combination Cabazitaxel/Carboplatin
  
• Episode 6: Optimizing Patient Selection for Cabazitaxel Therapy in Metastatic CRPC
• Episode 7: Metastatic CRPC: Selecting Patients for Cabazitaxel or Radiotherapy
• Episode 8: Addressing Barriers to Care in Metastatic Castration-Resistant Prostate Cancer
• Episode 9: Metastatic CRPC Management: Future Directions in Care

Watch each episode here.